Abstract
Stem cell transplantation has played a role in the management of diffuse large-cell lymphoma for decades. The optimal source of the stem cells and the proper composition of the cellular graft product has not been defined. The field is changing rapidly and the future is likely to hold improvements and requirements that will further benefit the patient!.
Original language | English (US) |
---|---|
Pages (from-to) | S23-S30 |
Journal | Annals of Oncology |
Volume | 9 |
Issue number | SUPPL. 1 |
DOIs | |
State | Published - 1998 |
Keywords
- Blood cell transplant
- Marrow transplant
ASJC Scopus subject areas
- Hematology
- Oncology